Nanjing Medlander Medical Technology Co.,Ltd.

SHSE:688273 Stock Report

Market Cap: CN¥2.4b

Nanjing Medlander Medical TechnologyLtd Past Earnings Performance

Past criteria checks 0/6

Nanjing Medlander Medical TechnologyLtd's earnings have been declining at an average annual rate of -3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 4.7% per year. Nanjing Medlander Medical TechnologyLtd's return on equity is 7.9%, and it has net margins of 26.6%.

Key information

-3.0%

Earnings growth rate

-17.1%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate4.7%
Return on equity7.9%
Net Margin26.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd (SHSE:688273)

Nov 08
Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd (SHSE:688273)

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd (SHSE:688273)

Nov 08
Weak Statutory Earnings May Not Tell The Whole Story For Nanjing Medlander Medical TechnologyLtd (SHSE:688273)

Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) Stock Rockets 29% But Many Are Still Ignoring The Company

Mar 06
Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) Stock Rockets 29% But Many Are Still Ignoring The Company

Revenue & Expenses Breakdown

How Nanjing Medlander Medical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688273 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2438110113456
30 Jun 2436510413256
31 Mar 243369413059
31 Dec 233419012858
30 Sep 2336910813356
30 Jun 2339813413352
31 Mar 2341113312545
31 Dec 2237712212041
30 Sep 2240913912340
30 Jun 2237111011339
31 Mar 2235611911037
31 Dec 2134211810337
31 Dec 203371229341
31 Dec 192561067725
31 Dec 18143564319

Quality Earnings: 688273 has a high level of non-cash earnings.

Growing Profit Margin: 688273's current net profit margins (26.6%) are lower than last year (29.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688273's earnings have declined by 3% per year over the past 5 years.

Accelerating Growth: 688273's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688273 had negative earnings growth (-6.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688273's Return on Equity (7.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 04:29
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nanjing Medlander Medical Technology Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tielin ChenTopsperity Securities